ACCF/ACG/AHA 2010 Expert Consensus Document on the concomitant use of proton pump inhibitors and thienopyridines: a focused update of the ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents.
Neena S
NS
Abraham
Mark A
MA
Hlatky
Elliott M
EM
Antman
Deepak L
DL
Bhatt
David J
DJ
Bjorkman
Craig B
CB
Clark
Curt D
CD
Furberg
David A
DA
Johnson
Charles J
CJ
Kahi
Loren
L
Laine
Kenneth W
KW
Mahaffey
Eamonn M
EM
Quigley
James
J
Scheiman
Laurence S
LS
Sperling
Gordon F
GF
Tomaselli
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000008:administration & dosage* / Q000009:adverse effects* / Q000378:metabolism; D001189:Aryl Hydrocarbon Hydroxylases / Q000378:metabolism; D001241:Aspirin / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D002318:Cardiovascular Diseases / Q000188:drug therapy; D000077144:Clopidogrel; D065731:Cytochrome P-450 CYP2C19; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced* / Q000517:prevention & control; D006635:Histamine H2 Antagonists / Q000008:administration & dosage* / Q000009:adverse effects* / Q000378:metabolism; D006801:Humans; D010879:Piperazines / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D010975:Platelet Aggregation Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects* / Q000378:metabolism; D000068799:Prasugrel Hydrochloride; D054328:Proton Pump Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects* / Q000378:metabolism; D058921:Purinergic P2Y Receptor Antagonists / Q000008:administration & dosage* / Q000009:adverse effects* / Q000378:metabolism; D012307:Risk Factors; D058924:Thienopyridines / Q000008:administration & dosage* / Q000009:adverse effects* / Q000378:metabolism; D013876:Thiophenes / Q000008:administration & dosage / Q000009:adverse effects / Q000378:metabolism; D013988:Ticlopidine / Q000008:administration & dosage / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000378:metabolism
D000894:Anti-Inflammatory Agents, Non-Steroidal; D006635:Histamine H2 Antagonists; D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D058921:Purinergic P2Y Receptor Antagonists; D058924:Thienopyridines; D013876:Thiophenes; D000077144:Clopidogrel; D001189:Aryl Hydrocarbon Hydroxylases; C045793:CYP2C19 protein, human; D065731:Cytochrome P-450 CYP2C19; D000068799:Prasugrel Hydrochloride; D013988:Ticlopidine; D001241:Aspirin